A comparative analysis of bone formation induced by human demineralized freeze-dried bone and enamel matrix derivative in rat calvaria critical-size bone defects

Journal of Periodontology

Volumn 79, Issue 7, 2008, Pages 1217-1224

  Intini, Giuseppe ^a,b   Andreana, Sebastiano ^c   Buhite, Robert J ^b   Bobek, Libuse A ^b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

Bone morphogenetic protein 2; Bone regeneration; Demineralized bone

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DRUG CARRIER; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; BONE MATRIX; BONE REGENERATION; BONE TRANSPLANTATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FREEZE DRYING; HISTOLOGY; HUMAN; METHODOLOGY; OSTEOCYTE; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT; SKULL; SPRAGUE DAWLEY RAT; TISSUE PRESERVATION;

ANIMALS; BONE DEMINERALIZATION TECHNIQUE; BONE DISEASES; BONE MATRIX; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE TRANSPLANTATION; COLLAGEN; DENTAL ENAMEL PROTEINS; DRUG CARRIERS; FEMALE; FREEZE DRYING; HUMANS; OSTEOCYTES; OSTEOGENESIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SKULL; TISSUE PRESERVATION; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA;

EID: 47749152229     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070435     Document Type: Article

References (48)

1. Bostrom MP, Saleh KJ, Einhorn TA. Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop Clin North Am 1999;30:647-658.
2. Oliver RC, Brown LJ, Löe H. Periodontal diseases in the United States population. J Periodontol 1998;69:269-278.
3. Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 2001;10(Suppl. 2):S96-S101.
4. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: State of the art and future trends. Macromol Biosci 2004;4:743-765.
5. Libin BM, Ward HL, Fishman L. Decalcified, lyophilized bone allografts for use in human periodontal defects. J Periodontol 1975;46:51-56.
6. Pacaccio DJ, Stern SF. Demineralized bone matrix: Basic science and clinical applications. Clin Podiatr Med Surg 2005;22:599-606.
7. Stevenson S. Enhancement of fracture healing with autogenous and allogeneic bone grafts. Clin Orthop Relat Res 1998;S239-S246.
8. Giannobile WV, Somerman MJ. Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol 2003;8:193-204.
9. Heden G, Wennstrom JL. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J Periodontol 2006;77:295-301.
10. Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarman HJ. Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 2005;87:1367-1378.
11. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84-A:2123-2134.
12. Szpalski M, Gunzburg R. Recombinant human bone morphogenetic protein-2: A novel osteoinductive alternative to autogenous bone graft? Acta Orthop Belg 2005;71:133-148.
13. Becker W, Urist MR, Tucker LM, Becker BE, Ochsenbein C. Human demineralized freeze-dried bone: Inadequate induced bone formation in athymic mice. A preliminary report. J Periodontol 1995;66:822-828.
14. Pinholt EM, Haanaes HR, Roervik M, Donath K, Bang G. Alveolar ridge augmentation by osteoinductive materials in goats. Scand J Dent Res 1992;100:361-365.
15. Schwartz Z, Mellonig JT, Carnes DL Jr., et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol 1996;67:918-926.
16. Becker W, Clokie C, Sennerby L, Urist MR, Becker BE. Histologic findings after implantation and evaluation of different grafting materials and titanium micro screws into extraction sockets: Case reports. J Periodontol 1998;69:414-421.
17. Becker W, Urist M, Becker BE, et al. Clinical and histologic observations of sites implanted with intraoral autologous bone grafts or allografts. 15 human case reports. J Periodontol 1996;67:1025-1033.
18. Feighan JE, Davy D, Prewett AB, Stevenson S. Induction of bone by a demineralized bone matrix gel: A study in a rat femoral defect model. J Orthop Res 1995;13:881-891.
19. Ozturk A, Yetkin H, Memis L, Cila E, Bolukbasi S, Gemalmaz C. Demineralized bone matrix and hydroxyapatite/tri-calcium phosphate mixture for bone healing in rats. Int Orthop 2006;30:147-152.
20. Cortellini P, Bowers GM. Periodontal regeneration of intrabony defects: An evidence-based treatment approach. Int J Periodontics Restorative Dent 1995;15:128-145.
21. Machtei EE, Schallhorn RG. Successful regeneration of mandibular Class II furcation defects: An evidence-based treatment approach. Int J Periodontics Restorative Dent 1995;15:146-167.
22. Rosen PS, Marks MH, Bowers GM. Regenerative therapy in the treatment of maxillary molar Class II furcations: Case reports. Int J Periodontics Restorative Dent 1997;17:516-527.
23. Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Ann Periodontol 2003;8:227-265.
24. Laurell L, Gottlow J, Zybutz M, Persson R. Treatment of intrabony defects by different surgical procedures. A literature review. J Periodontol 1998;69:303-313.
25. Heden G, Wennstrom J, Lindhe J. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. J Clin Periodontol 1999;26:855-860.
26. Heijl L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-714.
27. Zetterstrom O, Andersson C, Eriksson L, et al. Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontol 1997;24:697-704.
28. Boyan BD, Weesner TC, Lohmann CH, et al. Porcine fetal enamel matrix derivative enhances bone formation induced by demineralized freeze dried bone allograft in vivo. J Periodontol 2000;71:1278-1286.
29. Donos N, Kostopoulos L, Tonetti M, Karring T, Lang NP. The effect of enamel matrix proteins and deproteinized bovine bone mineral on heterotopic bone formation. Clin Oral Implants Res 2006;17:434-438.
30. Kawana F, Sawae Y, Sahara T, et al. Porcine enamel matrix derivative enhances trabecular bone regeneration during wound healing of injured rat femur. Anat Rec 2001;264:438-446.
31. Yoneda S, Itoh D, Kuroda S, et al. The effects of enamel matrix derivative (EMD) on osteoblastic cells in culture and bone regeneration in a rat skull defect. J Periodontal Res 2003;38:333-342.
32. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop 1986;205:299-308.
33. Intini G, Andreana S, Intini FE, Buhite RJ, Bobek LA. Calcium sulfate and platelet-rich plasma make a novel osteoinductive biomaterial for bone regeneration. J Transl Med 2007;5:13.
34. Marden LJ, Hollinger JO, Chaudhari A, Turek T, Schaub RG, Ron E. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res 1994;28:1127-1138.
35. Bonadio J, Smiley E, Patil P, Goldstein S. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 1999;5:753-759.
36. Lutolf MP, Weber FE, Schmoekel HG, et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003;21:513-518.
37. Schmitz JP, Schwartz Z, Hollinger JO, Boyan BD. Characterization of rat calvarial nonunion defects. Acta Anat (Basel) 1990;138:185-192.
38. An YH, Friedman RJ. Animal models of bone defect repair. In: An YH, Friedman RJ, eds. Animal Models in Orthopaedic Research. Boca Raton, FL: CRC Press; 1999:241-260.
39. Edwards JT, Diegmann MH, Scarborough NL. Osteoinduction of human demineralized bone: Characterization in a rat model. Clin Orthop Relat Res 1998;219-228.
40. Turonis JW, McPherson JC 3rd, Cuenin MF, Hokett SD, Peacock ME, Sharawy M. The effect of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol 2006;32:55-62.
41. th ed. McLean, VA: American Association of Tissue Banks; 2006.
42. American Academy of Periodontology. Tissue banking of bone allografts used in periodontal regeneration. J Periodontol 2001;72:834-838.
43. Rosen V. BMP and BMP inhibitors in bone. Ann N Y Acad Sci 2006;1068:19-25.
44. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87:2220-2224.
45. Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 1982;196:100-109.
46. Suzuki S, Nagano T, Yamakoshi Y, et al. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-fbetag. J Dent Res 2005;84:510-514.
47. Iwata T, Morotome Y, Tanabe T, Fukae M, Ishikawa I, Oida S. Noggin blocks osteoinductive activity of porcine enamel extracts. J Dent Res 2002;81:387-391.
48. Kawase T, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodontal Res 2001;36:367-376.